# Semax vs Selank: How They Differ in Nootropic Research

**Quick answer:** Semax and Selank are both ACTH/peptide-derived nootropic research compounds, but they’re studied for different things. Semax is researched mainly for cognition, focus, and neuroplasticity through BDNF and dopamine modulation. Selank is researched mainly for anti-anxiety (anxiolytic) effects through GABA and enkephalin pathways. Researchers often study them together as a stimulating-plus-calming pair. *Sold for research use only.*

## The core distinction

The simplest framing: [**Semax**](https://portaltowellness.net/shop/semax-10mg-vial/) is the “focus/neuroplasticity” research peptide; [**Selank**](https://portaltowellness.net/shop/selank-10mg-vial/) is the “calm/anxiolytic” research peptide. Both raise BDNF in hippocampal tissue, but their primary mechanisms and research applications diverge from there.

## Side-by-side

| | Semax | Selank |
| --- | --- | --- |
| **Derived from** | ACTH(4–10) fragment analogue | Tuftsin analogue |
| **Primary studied mechanism** | BDNF/NGF + dopamine and serotonin modulation; TrkB activation | Enkephalinase inhibition (extends enkephalin tone); GABAergic + BDNF |
| **Main research angle** | Cognition, focus, neuroplasticity, neuroprotection | Anxiolytic, mood stabilization, stress response |
| **Typical research framing** | “Stimulating / pro-cognitive” | “Calming / anti-anxiety” |

## Mechanisms in more detail

**Semax** rapidly increases hippocampal BDNF-mRNA and TrkB phosphorylation in animal models, and modulates dopamine and serotonin — the basis for its use in cognition, attention, and neuroplasticity research, plus neuroprotection models (e.g., ischemia research).

**Selank** inhibits enkephalinase, extending the half-life of endogenous enkephalins and potentiating opioid tone *without* directly stimulating opioid receptors, alongside GABAergic signaling and hippocampal BDNF upregulation — the basis for its anxiolytic and mood-research applications.

## Why researchers study them together

Anxiety-related stress signaling can suppress BDNF and impair neuroplasticity. Because Selank reduces stress-pathway activation while Semax drives neurotrophic signaling, the pair is studied as a dual-mechanism tool for stress-cognition interaction models — a stimulating + calming combination.

## Frequently asked questions

**What is the difference between Semax and Selank?**
Semax is studied for cognition and neuroplasticity via BDNF and dopamine; Selank is studied for anti-anxiety effects via GABA and enkephalin pathways.

**Which is the “focus” peptide and which is the “calm” peptide?**
In research framing, Semax is the focus/neuroplasticity compound and Selank is the calming/anxiolytic compound.

**Do both increase BDNF?**
Yes — both upregulate hippocampal BDNF, but Semax’s primary angle is neurotrophic/dopaminergic while Selank’s is anxiolytic.

**Can they be studied together?**
Yes — the stimulating-plus-calming pairing is a common dual-mechanism research design.

**Are these for human use?**
No. Portal to Wellness sells these strictly for laboratory and research use only. Nothing here is medical advice.

## Primary-literature anchors

Cite primary sources: Semax BDNF/TrkB and dopamine research (Russian neuropharmacology literature); [Selank enkephalinase-inhibition and anxiolytic research](https://portaltowellness.net/selank-and-neuroimmune-modulation/) . Link via PubMed.

---

*For research use only. Not for human or veterinary use, diagnosis, treatment, or prevention of any condition. Not evaluated by the FDA. Author: Charles Fowler. Last updated: May 2026.*

---

Source: https://portaltowellness.net/semax-vs-selank/
Research use only. Terms: https://portaltowellness.net/research-use-only/